SIRPαFc treatment targets human acute myeloid leukemia stem cells.

ABSTRACT:

SUBMITTER: Galkin O 

PROVIDER: S-EPMC7776262 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature